Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Tanya Lewis > Profile

Tanya Lewis

Affiliations

  • Director at Diamedica Therapeutics Inc. (DMAC), 2025-06-03
  • Chief Dev. Op. Officer at Replimune Group Inc. (REPL), 2023-06-16
  • Evp, Chief Reg. Affairs at Karyopharm Therapeutics Inc. (KPTI), 2021-03-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
REPL $23.45 817 $19,158.65 135,293 2023-06-13 Filing
REPL $24.10 12,043 $290,236.30 136,110 2023-06-13 Filing
REPL $18.05 12,207 $220,336.35 148,153 2023-05-16 Filing
REPL $14.59 5,473 $79,851.07 120,360 2022-05-16 Filing
KPTI $15.52 2,046 $31,752.08 4,143 2021-02-11 Filing